LON:CLAI Cel AI (CLAI) Share Price, News & Analysis GBX 0.05 0.00 (0.00%) (As of 11/21/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitors About Cel AI Stock (LON:CLAI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cel AI alerts:Sign Up Key Stats Today's Range 0.05▼ 0.0650-Day Range 0.05▼ 0.0952-Week Range 0.05▼ 0.52Volume205,345 shsAverage Volume2.54 million shsMarket Capitalization£316,181.25P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online. The company was formerly known as Cellular Goods PLC and changed its name to Cel AI PLC in February 2024. Cel AI PLC was incorporated in 2018 and is based in London, United Kingdom.Read More… Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Receive CLAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cel AI and its competitors with MarketBeat's FREE daily newsletter. Email Address CLAI Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com CLAI Stock Analysis - Frequently Asked Questions How have CLAI shares performed this year? Cel AI's stock was trading at GBX 0.15 on January 1st, 2024. Since then, CLAI stock has decreased by 65.9% and is now trading at GBX 0.05. View the best growth stocks for 2024 here. How do I buy shares of Cel AI? Shares of CLAI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeLON SectorConsumer Defensive Industry Household & Personal Products Sub-IndustryN/A Current SymbolLON:CLAI CUSIPN/A CIKN/A Webwww.getcel.ai PhoneN/AFaxN/AEmployees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-2,110,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-86.60% Return on Assets-50.24% Debt Debt-to-Equity RatioN/A Current Ratio26.54 Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares602,250,000Free FloatN/AMarket Cap£316,181.25 OptionableN/A Beta-1.60 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (LON:CLAI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cel AI PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Cel AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.